Online citations, reference lists, and bibliographies.
← Back to Search

Survivin Expression And Resistance To Anticancer Treatments: Perspectives For New Therapeutic Interventions.

N. Zaffaroni, M. Daidone
Published 2002 · Medicine, Biology

Save to my Library
Download PDF
Analyze on Scholarcy Visualize in Litmaps
Share
Reduce the time it takes to create your bibliography by a factor of 10 by using the world’s favourite reference manager
Time to take this seriously.
Get Citationsy
Survivin is a structurally unique member of the inhibitors of apoptosis protein (IAP) family that is involved in both control of cell division and inhibition of apoptosis. Its anti-apoptotic function seems to be related to its ability to directly or indirectly inhibit caspases, although the precise role of survivin in the modulation of the caspase cascade has not been fully elucidated. Survivin has been described to be selectively expressed in the most common human neoplasms and to be associated with clinical tumour progression. Moreover, the protein appears to be involved in tumour cell resistance to some anticancer agents and ionizing radiation. On the basis of these findings survivin has been proposed as a promising target for new anticancer interventions. In in vitro and in vivo studies targeting survivin with antisense oligonucleotides, dominant negative mutants or ribozymes have shown to induce apoptosis, reduce tumour-growth potential and sensitise tumour cells to chemotherapeutic drugs such as Taxol, cisplatin and etoposide, gamma-irradiation, and immunotherapy.
This paper references
10.1096/fasebj.9.10.7615156
Xa receptor EPR‐1
D. Altieri (1995)
10.1016/S0092-8674(00)80430-4
Caspases: Intracellular Signaling by Proteolysis
G. Salvesen (1997)
Gain of chromosome 17 is the most frequent abnormality detected in neuroblastoma by comparative genomic hybridization.
D. Plantaz (1997)
10.1038/NM0897-917
A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
G. Ambrosini (1997)
10.1016/S0955-0674(97)80069-5
Transducing signals of life and death.
J. Yuan (1997)
10.1038/25141
Control of apoptosis and mitotic spindle checkpoint by survivin
F. Li (1998)
10.1074/jbc.273.18.11177
Induction of Apoptosis and Inhibition of Cell Proliferation bysurvivin Gene Targeting*
G. Ambrosini (1998)
10.1126/SCIENCE.281.5381.1322
The Bcl-2 protein family: arbiters of cell survival.
J. Adams (1998)
10.1101/GAD.12.11.1551
Proteases to die for.
V. Cryns (1998)
Survivin apoptosis: an interloper between cell death and cell proliferation in cancer.
D. Altieri (1999)
The cancer antiapoptosis mouse survivin gene: characterization of locus and transcriptional requirements of basal and cell cycle-dependent expression.
F. Li (1999)
10.1200/JCO.1999.17.9.2941
Dysregulation of apoptosis in cancer.
John Calvin Reed (1999)
10.1046/J.1523-1747.1999.00776.X
Expression and targeting of the apoptosis inhibitor, survivin, in human melanoma.
D. Grossman (1999)
10.1038/70487
Analysis of human transcriptomes
V. G. Velculescu (1999)
10.1101/GAD.13.3.239
IAP family proteins--suppressors of apoptosis.
Q. Deveraux (1999)
Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties.
C. Mahotka (1999)
10.1038/70242
Pleiotropic cell-division defects and apoptosis induced by interference with survivin function
F. Li (1999)
10.1136/BMJ.321.7271.1295
Drug Resistance Updates
P. Huovinen (2000)
A novel antisense oligonucleotide targeting survivin expression induces apoptosis and sensitizes lung cancer cells to chemotherapy.
R. Olie (2000)
10.1073/PNAS.240390697
Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin.
D. S. O'Connor (2000)
10.1038/SJ.NEO.7900091
Down-regulation of survivin by antisense oligonucleotides increases apoptosis, inhibits cytokinesis and anchorage-independent growth.
J. Chen (2000)
10.1038/35037710
The biochemistry of apoptosis
M. Hengartner (2000)
10.1111/j.1349-7006.2000.tb00906.x
Survivin as a Radioresistance Factor in Pancreatic Cancer
K. Asanuma (2000)
Antibody response to the tumor-associated inhibitor of apoptosis protein survivin in cancer patients.
J. Rohayem (2000)
Catalytic nucleic acids: from lab to applications.
L. Sun (2000)
10.1016/S0960-9822(00)00769-7
Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype
A. Uren (2000)
10.1016/S0002-9440(10)64742-6
Control of apoptosis during angiogenesis by survivin expression in endothelial cells.
D. S. O'Connor (2000)
10.1038/35037747
From bench to clinic with apoptosis-based therapeutic agents
D. Nicholson (2000)
10.1054/DRUP.2001.0213
If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells.
I. Roninson (2001)
10.1016/S0002-9440(10)64131-4
Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting.
M. Mesri (2001)
10.1093/JNCI/93.20.1541
Effects of survivin antagonists on growth of established tumors and B7-1 immunogene therapy.
J. Kanwar (2001)
10.1073/PNAS.98.2.635
Inhibition of melanoma tumor growth in vivo by survivin targeting.
D. Grossman (2001)
10.1054/DRUP.2001.0193
Apoptosis: mediator or mode of cell killing by anticancer agents?
J. Brown (2001)
10.1046/j.1471-4159.2001.00596.x
Survivin inhibition induces human neural tumor cell death through caspase‐independent and ‐dependent pathways
S. L. Shankar (2001)
10.1054/DRUP.2001.0187
Does resistance to apoptosis affect clinical response to antitumor drugs?
P. Borst (2001)
10.1016/S0304-3835(01)00499-2
DNA demethylase is expressed in ovarian cancers and the expression correlates with demethylation of CpG sites in the promoter region of c-erbB-2 and survivin genes.
M. Hattori (2001)
10.1054/DRUP.2001.0188
Apoptosis is critical for drug response in vivo.
C. Schmitt (2001)
10.1172/JCI12983
Cancer gene therapy using a survivin mutant adenovirus.
M. Mesri (2001)
10.1016/S1471-4914(01)02026-3
Apoptosis-regulating proteins as targets for drug discovery.
John Calvin Reed (2001)
10.1016/S1471-4914(01)02243-2
The molecular basis and potential role of survivin in cancer diagnosis and therapy.
D. Altieri (2001)
10.1001/JAMA.285.3.324
Urine detection of survivin and diagnosis of bladder cancer.
S. D. Smith (2001)
10.1096/fj.01-0280fje
Human inhibitor of apoptosis protein (IAP) survivin participates in regulation of chromosome segregation and mitotic exit
M. Kallio (2001)
10.1172/JCI14123
The Survivin saga goes in vivo.
John Calvin Reed (2001)
10.1054/DRUP.2001.0223
The role of caspase-8 in resistance to cancer chemotherapy.
P. Kim (2001)
Survivin exists in immunochemically distinct subcellular pools and is involved in spindle microtubule function.
Paola Fortugno (2002)
10.1172/JCI14891
Ribozyme-mediated attenuation of survivin expression sensitizes human melanoma cells to cisplatin-induced apoptosis.
M. Pennati (2002)
Regulation of microtubule stability and mitotic progression by survivin.
A. Giodini (2002)
10.1038/sj.onc.1205353
Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway
A. Mirza (2002)
10.1073/pnas.072586399
A role for survivin in chemoresistance of endothelial cells mediated by VEGF
J. Tran (2002)



This paper is referenced by
10.1016/j.apsb.2020.11.015
The disruption of protein−protein interactions with co-chaperones and client substrates as a strategy towards Hsp90 inhibition
Michael A. Serwetnyk (2021)
10.1177/10915818211014170
Survivin Promoter-Driven DFF40 Gene Expression Sensitizes Melanoma Cancer Cells to Chemotherapy
G. Minaiyan (2021)
10.1038/s41366-020-0630-7
Weight loss normalizes enhanced expression of the oncogene survivin in visceral adipose tissue and blood leukocytes from individuals with obesity
Andrea G. Izquierdo (2020)
10.1016/j.ygeno.2020.09.053
Unraveling novel survivin mRNA transcripts in cancer cells using an in-house developed targeted high-throughput sequencing approach.
Panagiotis G Adamopoulos (2020)
10.1016/j.yexcr.2020.111860
A role for ceramide glycosylation in resistance to oxaliplatin in colorectal cancer.
J. Madigan (2020)
10.1016/BS.ACC.2019.07.011
Epigenetic reprogramming and potential application of epigenetic-modifying drugs in acquired chemotherapeutic resistance.
Logeswari Ponnusamy (2020)
10.1177/2472630318816668
siRNA-Conjugated Nanoparticles to Treat Ovarian Cancer
Christopher Halbur (2019)
10.3892/OL.2019.10474
Response prediction to oxaliplatin plus 5-fluorouracil chemotherapy in patients with colorectal cancer using a four-protein immunohistochemical model.
J. Gu (2019)
10.1002/asia.201900587
An inhibitor of the interaction of survivin with Smac in mitochondria promote apoptosis.
I. Shin (2019)
10.5812/IJCM.87773
Myeloid Cell Leukemia-1 (MCL-1) siRNA Therapy Showed Cytotoxic Effect on T Cells Acute Lymphoblastic Leukemia
Shaghayegh Askarian-Amiri (2019)
10.1002/cmdc.201900450
The Application of Biomaterials in the Treatment of Platinum‐Resistant Ovarian Cancer
A. Levy (2019)
10.3389/fonc.2019.01345
Survivin Promotes Piperlongumine Resistance in Ovarian Cancer
X. Nan (2019)
10.1016/j.pep.2019.04.003
Cloning, expression, and purification of the recombinant pro-apoptotic dominant-negative survivin T34A-C84A protein in Escherichia coli.
Shing-Ling Tsai (2019)
10.2147/IJN.S161426
Smart polymeric nanoparticles with pH-responsive and PEG-detachable properties for co-delivering paclitaxel and survivin siRNA to enhance antitumor outcomes
Mingji Jin (2018)
10.3892/ijo.2018.4365
Survivin knockdown induces senescence in TTF-1-expressing, KRAS-mutant lung adenocarcinomas
Toshiyuki Sumi (2018)
10.1080/21691401.2017.1392969
Enhancement of chemosensitivity by simultaneously silencing of Mcl-1 and Survivin genes using small interfering RNA in human myelomonocytic leukaemia
M. Jafarlou (2018)
Drug Delivery Strategies For The Treatment Of Advanced Lung Cancer And Various Lung Metastases
Elizabeth R Bielski (2018)
10.18433/jpps29726
Functionalized Caprolactone-Polyethylene Glycol Based Thermo-Responsive Hydrogels of Silibinin for the Treatment of Malignant Melanoma.
B. Makhmalzadeh (2018)
10.1007/s00432-018-2580-1
Tumor expression of survivin, p53, cyclin D1, osteopontin and fibronectin in predicting the response to neo-adjuvant chemotherapy in children with advanced malignant peripheral nerve sheath tumor
G. Karpinsky (2018)
10.3892/ol.2018.9426
Butein induces apoptotic cell death of human cervical cancer cells
Pei-Yu Yang (2018)
10.1016/j.amjms.2017.08.002
A Study of Novel siRNA Targeting Survivin Delivered by Nanoparticles
C. Feng (2017)
SURVIVIN EXPRESSION IN COLORECTAL ADENOCARCINOMAS
Dr. S. Brihadisvarar (2017)
10.7150/thno.20005
Subcellular Localization of Survivin Determines Its Function in Cardiomyocytes
Tien-Jui Tsang (2017)
The Effect of Snail1 Gene Silencing by siRNA in Metastatic Breast Cancer Cell Lines
Mansoor Aletaha (2017)
10.1016/j.ijpharm.2017.09.060
Co-delivery strategies to overcome multidrug resistance in ovarian cancer.
I. Khan (2017)
10.3892/etm.2017.4501
Small interfering RNA targeting of the survivin gene inhibits human tumor cell growth in vitro
Z. Zhang (2017)
10.3892/ol.2017.6404
Evaluation of antitumor activity of survivin short interfering RNA delivered by lipid nanoparticles in colon cancer in vitro and in vivo
T. Wang (2017)
10.1007/s11427-017-9230-2
Epigenetic mechanism of survivin dysregulation in human cancer
H. Lyu (2017)
10.1016/j.canlet.2017.08.031
Palbociclib, a selective CDK4/6 inhibitor, enhances the effect of selumetinib in RAS-driven non-small cell lung cancer.
Jianya Zhou (2017)
10.1016/j.biopha.2017.01.030
Therapeutic effects of bach1 siRNA on human breast adenocarcinoma cell line.
Mansoor Aletaha (2017)
10.1016/j.amjms.2017.08.002
Novel Survivin‐Targeted Small Interfering RNA Delivered by Nanoparticles
C. Feng (2017)
10.1124/mol.115.100206
Chronic Oxidative Stress Increases Resistance to Doxorubicin-Induced Cytotoxicity in Renal Carcinoma Cells Potentially Through Epigenetic Mechanism
Logeswari Ponnusamy (2016)
See more
Semantic Scholar Logo Some data provided by SemanticScholar